Medications listed are available on OH EPIC Formulary, unless otherwise noted. Not all formulary medications are available at each facility. Please refer to your local pharmacy for available inventory.
Indication: For adults with multiple myeloma who have received at least two prior therapies including Revlimid and a proteasome inhibitor
Service Line: Oncology
Location: Infusion centers
Prior Authorization Required
CriteriaofUse/Restriction:
in combination with pomalidomide and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least 2 prior therapies including lenalidomide and a proteasome inhibitor.
in combination with carfilzomib and dexamethasone, for the treatment of adult patients with relapsed or refractory multiple myeloma who have who have received 1 to 3 prior lines of therapy.
Restrictions: